Should all sexually active young women in Hungary be screened for Chlamydia trachomatis?

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 106, Issue 1, 2003, Pages 55-59

  Nyári, Tibor ^a   Woodward, Mark ^b   Kovács, L ászló ^c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Chlamydia trachomatis; Cost effectiveness analysis; Perinatal mortality; Preventive care

Indexed keywords

ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DISEASE COURSE; ECONOMICS; HEALTH CARE POLICY; HUMAN; HUNGARY; MEDICAL EXAMINATION; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; SCREENING TEST; ADOLESCENT; ADULT; CHLAMYDIA TRACHOMATIS; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; MASS SCREENING; METHODOLOGY; PREGNANCY COMPLICATION; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HUNGARY; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR;

EID: 0037427578     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00222-1     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention (CDCP). Recommendations for the prevention and management of Chlamydia trachomatis infections. MMWR Morb Mortal Weekly Rep 1993;42:1-39.
2. Scholes D., Stergachis A., Ichikawa L.E., Heidrich F.E., Holmes K.K., Stamm W.E. Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet. Gynecol. 91(6):1998;993-997.
3. Nyári T., Woodward M., Mészáros G., Karsai J., Kovács L. Chlamydia trachomatis infection and the risk of perinatal mortality in Hungary. J. Perinat. Med. 29:2001;55-59.
4. Nyári T., Deák J., Nagy E.et al. Epidemiological study of Chlamydia trachomatis infection in pregnant women in Hungary. Sex Transm. Infect. 74:1998;213-215.
5. Nyári T., Nyári C., Woodward M.et al. Screening for Chlamydia trachomatis in asymptomatic women in Hungary: an epidemiological and cost-effectiveness analysis. Acta Obstet. Gynecol. Scand. 80:2001;300-306.
6. Paavonen J. Pelvic inflammatory disease: from diagnosis to prevention. Dermatol. Clin. 16(4):1998;747-756.
7. Sziller I., Ujhazy A., Bardoczy Z., Szendei G., Papp Z. Incidence and mortality of extrauterine pregnancy in Hungary (1931-1995). Orv. Hetil. 139:1998;493-498.
8. Genç M., Mardh P.A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann. Intern. Med. 124:1996;1-7.
9. Westrom L., Joesoef R., Reynolds G., Hagdu A., Thomson S.E. Pelvic inflammatory disease and fertility: a cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm. Dis. 19:1992;185-192.
10. Central Statistical Office(KSH): Demographical Data. Budapest, Hungary, 1996.
11. Jones R.B., Mammel J.B., Shepard M.K., Fisher R.R. Recovery of Chlamydia trachomatis from the endometrium of women at risk for chlamydial infection. Am. J. Obstet. Gynecol. 155:1996;35-39.
12. Magid D., Douglas J.M. Jr., Schwartz J.S. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann. Intern. Med. 124:1996;389-399.
13. Petitti DB. Meta-Analysis, Decision Analysis and Cost-Effectiveness Analysis. Oxford: Oxford University Press, 1994.
14. Marrazzo J.M., Celum C.L., Hillis S.D., Fine D., DeLisle S., Handsfield H.H. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: implications for a national chlamydia control strategy. Sex Transm. Dis. 24:1997;131-141.
15. Warszawski J., Meyer L., Weber P. Criteria for selective screening of cervical Chlamydia trachomatis infections in women attending private gynecology practices. Eur. J. Obstet. Gynecol. Reprod. Biol. 86:1999;5-10.
16. Macmillan S., McKenzie H., Flett G., Templeton A. Which women should be tested for Chlamydia trachomatis? BJOG. 107(9):2000;1088-1093.
17. Vile Y., Carroll S.G., Watts P., Ward M., Nicolaides K.H. Chlamydia trachomatis infection in prelabour amniorrhexis. Br. J. Obstet. Gynaecol. 104:1997;1091-1103.
18. Ancel P.Y., Saurel-Cubizolles M.J., Di Renzo G.C., Papiernik E., Breart G. The EUROPOP group social differences of very preterm birth in Europe: interaction with obstetric history. Am. J. Epidemiol. 149:1999;908-915.
19. Haddix A.C., Hillis S.D., Kassler W.J. The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women. Sex Transm. Dis. 22:1995;274-280.
20. Vuylsteke B., Vandenbruaene M., Vandenbalcke P., Van Dyck E., Laga M. Chlamydia trachomatis prevalence and sexual behaviour among female adolescents in Belgium. Sex Transm. Infect. 75(3):1999;152-155.